4D Molecular Therapeutics
FDMT
FDMT
119 hedge funds and large institutions have $151M invested in 4D Molecular Therapeutics in 2025 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 43 increasing their positions, 40 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
5.85% less ownership
Funds ownership: 93.06% → 87.21% (-5.9%)
24% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 21
Holders
119
Holding in Top 10
–
Calls
$171K
Puts
$147K
Top Buyers
| 1 | +$1.55M | |
| 2 | +$939K | |
| 3 | +$737K | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$638K |
| 5 |
Raymond James Financial
St Petersburg,
Florida
|
+$598K |
Top Sellers
| 1 | -$3.28M | |
| 2 | -$3.16M | |
| 3 | -$2.19M | |
| 4 |
BlackRock
New York
|
-$1.99M |
| 5 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
-$1.33M |
